Azithromycin reduces spontaneous and induced inflammation in ΔF508 cystic fibrosis mice

BACKGROUND: Inflammation plays a critical role in lung disease development and progression in cystic fibrosis. Azithromycin is used for the treatment of cystic fibrosis lung disease, although its mechanisms of action are poorly understood. We tested the hypothesis that azithromycin modulates lung in...

Descripción completa

Detalles Bibliográficos
Autores principales: Legssyer, Rachida, Huaux, François, Lebacq, Jean, Delos, Monique, Marbaix, Etienne, Lebecque, Patrick, Lison, Dominique, Scholte, Bob J, Wallemacq, Pierre, Leal, Teresinha
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1637104/
https://www.ncbi.nlm.nih.gov/pubmed/17064416
http://dx.doi.org/10.1186/1465-9921-7-134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1637104/
https://www.ncbi.nlm.nih.gov/pubmed/17064416
http://dx.doi.org/10.1186/1465-9921-7-134

Ejemplares similares